Save time and get answers to complex questions with AI chat
Guselkumab patent expiration?Stribild expiry date?Patent expiration eu dabrafenib?What excipients are combined with ruxolitinib in apotex's medication?Patent expiration date of guselkumab?
See the DrugPatentWatch profile for Acalabrutinib
Yes. The FDA approved acalabrutinib on October 31, 2017. [1]
The FDA approval on October 31, 2017 was for acalabrutinib to treat mantle cell lymphoma (MCL) that has been treated previously. [1]
This approval date is listed in the FDA approval records for acalabrutinib (Calquence). [1]
[1] https://www.fda.gov/drugs/resources-information-approved-drugs/acalabrutinib-calquence
Other Questions About Acalabrutinib :